LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Carbonite, Inc. ("Carbonite" or "the Company") (NASDAQ:CARB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 7, 2019 and July 25, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before September 30, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Carbonite's Server Backup VM Edition product suffered from deep quality flaws and poor technology. The Company received many negative reviews of the product from its customers. The product was so flawed that it acted as a "disruptive" factor amongst Carbonite's sales force, constraining salespeople from closing several large deals in fiscal year 2019. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Carbonite, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561369

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Aclaris Therapeutics, Inc. ("Aclaris" or "the Company") (NASDAQ:ACRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. It was reported on June 20, 2019, that the FDA's Office of Prescription Drug Promotion (OPDP) released a letter which stated that a video advertisement for Aclaris's hydrogen peroxide topical solution, Eskata, "makes false or misleading claims" about its risk and efficacy. The FDA letter states that, "a direct-to-consumer video of an interview featuring a paid Aclaris spokesperson" was "especially concerning from a public health perspective because it fails to include information regarding the serious risks associated with Eskata, which bears warnings and precautions related to the risks of serious eye disorders…in the case of exposure to the eye and severe skin reactions including scarring." Based on this news, shares of Aclaris fell significantly over the next two trading sessions.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561368

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against 2U, Inc. ("2U" or "the Company") (NASDAQ:TWOU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between February 25, 2019 and July 30, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before October 7, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. 2U faced stiffening competition in the online education space, especially in the graduate program area. At the same time, the Company faced program-specific issues that hurt performance. These factors combined to make the Company's business model unsustainable, forcing it to slow program launches. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about 2U, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
www.schallfirm.com
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561367

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tencent Music Entertainment Group ("Tencent Music" or "the Company") (NYSE:TME) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Bloomberg reported on August 27, 2019, that Tencent Music is the subject of an investigation by China's antitrust authority, the State Administration of Market Regulation. The investigation focuses on exclusive licensing deals between the Company and record labels including Sony Music Entertainment. Based on this news, shares of Tencent Music fell by almost 7% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
www.schallfirm.com
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561366

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Match Group, Inc. ("Match" or "the Company") (NASDAQ:MTCH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The FTC announced on September 25, 2019, that it had sued Match for using exploitative marketing in the form of messaging from fake accounts to induce non-subscribers to sign up for the Company's service. According to FTC Bureau of Consumer Protection Director Adam Smith, "We believe that Match.com conned people into paying for subscriptions via messages the company knew were from scammers." The FTC also alleges that Match exposed its users to fraud and also engaged in deceptive practices such as making it intentionally difficult to cancel subscriptions.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Office: 310-301-3335
Cell: 424-303-1964
www.schallfirm.com
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561365

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Curaleaf Holdings, Inc. (“Curaleaf”or “the Company”) (OTCQX:CURLF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The FDA sent a warning letter to Curaleaf on July 22, 2019. The FDA letter stated that the Company was selling several CBD products on its website that were “misbranded drugs,” a violation of the Federal Food, Drug, and Cosmetic Act. Based on this news, shares of Curaleaf fell more than 7% on July 23, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561370

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ollie's Bargain Outlet Holdings, Inc. ("Ollie's" or "the Company") (NASDAQ:OLLI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ollie's claimed on August 28, 2019, that new stores had cannibalized the sales of existing stores at a higher than normal rate, resulting in a drop of comparable-store sales. The Company had also underestimated the demands of initial inventory and replenishment at the new stores. Ollie's admitted that a "bottleneck issue" had existed in the supply chain "for most all of Q2" and the Company had failed to fix it until "the last week of the quarter." Based on this news, shares of Ollie's fell by more than 27% on August 29, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 561362

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / MjLink.com Inc. a wholly owned subsidiary of Social Life Network, Inc. (OTCQB:WDLF), is pleased to announce FluroTech as a Featured Presenter at their MjMicro Conference in Beverly Hills on October 16th at the Sofitel Hotel.

The MjMicro Conference is an invitational forum that unites publicly traded and emerging growth private cannabis companies that are led by seasoned executives, together with high net worth investors and financial analysts.

This one-day cannabis investor conference provides a rare opportunity for attendees to get real-time company updates from each of the presenting companies, and access to an assortment of well-known industry experts that will be speaking throughout the day.

During the conference Danny Dalla-Longa, CEO from FluroTech, LTD. (TEST, FLURF) will host a featured presentation to update investors and analysts on the latest developments. FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry.

FluroTech's patented spectroscopy and fluorescence-based technology allows for the testing, identification and quantification of organic and inorganic compounds contained within biological samples. Using this technology which was developed at the University of Calgary and the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits. The advantages of this technology which is its speed, accuracy, repeatability and ease of use has been designed to allow growers to optimize their crop production and increase their profitability.

To learn more about MjMicro Conference and request an invitation to attend, sponsor or present at the Beverly Hills conference, please visit: https://www.mjmicro.com/attend.

About MjLink.com, Inc.

MjLink.com Inc. a wholly owned subsidiary of Social Life Network, Inc. (OTCQB: WDLF), and is a cloud-based cannabis social network and digital media company based in Denver, Colorado. MjLink operates as a multinational cannabis technology and digital media organization with two separate social networks: WeedLife.com, a consumer-to-consumer social network and MjLink.com, a business-to-business social network. MjLink launched its first investor conference in NYC on June 25th, 2019. The MjMicro Conference was so successful that MjLink launched their MjInvest.com investor social network and virtual conference platform in August 2019. MjInvest.com is used by publicly traded companies and emerging private companies to connect, present and provide news flow to accredited online cannabis investors.

For more information about Social Life Network, visit www.SocialNetwork.ai.

Disclaimer

This news release may include forward-looking statements within the meaning of section 27A of the United States Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company's analysis of opportunities in the acquisition and development of various project interests and certain other matters. No information in this press release should be construed as any indication whatsoever of the Company's or MjLink's future financial results, revenues or stock price. There are no assurances that the Company will successfully take MjLink.com, Inc public as noted in previous press releases. These statements are made under the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein

CONTACT:

Investor Relations
IR@Social-Life-Network.com
855-933-3277

SOURCE: Social Life Network, Inc.

ReleaseID: 561360

NEW YORK, NY / ACCESSWIRE / September 27, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Curaleaf Holdings, Inc. (OTCQX:CURLF)

Investors Affected : November 21, 2018 – July 22, 2019

A class action has commenced on behalf of certain shareholders in Curaleaf Holdings, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Curaleaf, on its website and social media pages, marketed its CBD products to be used as drugs and dietary supplements, contrary to law; (2) Curaleaf also sold unapproved animal drugs on its website; (3) such conduct would result in a warning letter from the U.S. Food and Drug Administration; and (4) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/curaleaf-holdings-inc-loss-submission-form/?id=3747&from=1

International Flavors & Fragrances Inc. (NYSE:IFF)

Investors Affected : May 7, 2018 – August 5, 2019

A class action has commenced on behalf of certain shareholders in International Flavors & Fragrances Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Frutarom Industries Ltd. ("Frutarom"), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) senior management at Frutarom were aware of such improper payments; (3) as a result, Frutarom's financial results were materially overstated; (4) as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) the Company had not completed adequate due diligence before acquiring Frutarom; (6) as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/international-flavors-fragrances-inc-loss-submission-form/?id=3747&from=1

MacroGenics, Inc. (NASDAQGS:MGNX)

Investors Affected : February 6, 2019 – June 3, 2019

A class action has commenced on behalf of certain shareholders in MacroGenics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had conducted the progression-free survival ("PFS") and first interim overall survival ("OS") analyses for the SOPHIA trial by no later than October 10, 2018; (b) the October 2018 PFS analysis showed a 0.9 month improvement in PFS; and (c) the October 2018 OS interim analysis did not produce a statistically significant result and the interim OS Kaplan-Meier curves crossed in several spots (thereby violating the constant hazard assumption) and separated late.

Shareholders may find more information at https://securitiesclasslaw.com/securities/macrogenics-inc-loss-submission-form/?id=3747&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 561357